4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-059819
Chief Financial Officer sold 3,000 shares at $9.50 ($28,500)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-12-26 | Sale 10b5-1 | −3,000 | $9.50 | $28,500 | 93,400 | D |
| Open-market sales · 3,000 sh · avg $9.50 · $28,500 | |||||||
Loading xslF345X05/doc4.xml…